Influence of anthroposophical supportive medicine on treatment-related toxicity in children receiving cancer therapy
Completed
- Conditions
- Solid tumours, lymphoma and leukaemiaCancerLeukaemia of unspecified cell type
- Registration Number
- ISRCTN64676790
- Lead Sponsor
- Helixor Heilmittel GmbH and Co. (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 340
Inclusion Criteria
The trial will be open to patients being treated according to current protocols for solid tumours, lymphoma and leukaemia in the German Society for Paediatric Oncology and Haematology (GPOH), aged between 1 and 18 years
Exclusion Criteria
Current use of any experimental therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method